UPB Total Utang marang Modal Upstream Bio Corp

UPB (Upstream Bio Corp) - tandha merek perusahaan

The implementation of automation in antibody screening has accelerated drug development, and the financial leverage dynamics of Upstream Bio Inc (UPB) now reflect a current trend where the indicator value reaches 0.00. Upstream Bio Inc (UPB) is focusing on bringing an innovative treatment for severe asthma to market, relying on contract manufacturing organizations (CMO) for the production of monoclonal antibodies.

UPB Rasio Kabeh Utang marang Dana Pribadi Upstream Bio (12.10.2024 - 27.10.2026)

Rincian analitis perusahaan Upstream Bio Inc

- rega lan prakiraan konsensus rega:
Rega saham Upstream Bio|UPB - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar Upstream Bio|UPB - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Upstream Bio|UPB - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku upstreambio.com|UPB - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Upstream Bio Inc|UPB - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Upstream Bio Inc|UPB - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Upstream Bio
Analisis dhasar perusahaan:Upstream Bio - UPB
Produk dadi upstreambio.com

Minimizing debt risks is critical for assessing the stability of biopharmaceutical startups. The development of unique antibodies by Upstream Bio Inc (UPB) requires colossal investments in patent protection and R&D. The ratio of total liabilities to equity, reflected in the financial leverage coefficient (total debt-to-equity), determines the business's degree of dependence on external borrowing. This indicator measures the balance sheet's vulnerability to rising interest rates. A low value confirms the company's financial autonomy.

Pesaing wigati

ARGX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi BioNTech Inc.|Total Utang marang Modal ABVX|Total Utang marang Modal ADMA (ADMA Corp)|Utang marang Ekuitas Protagonist Therapeutics|immunovant.com - Rasio Kabeh Utang marang Dana Pribadi|KNSA: Utang marang Ekuitas|GRFS - Rasio Total Utang marang Ekuitas|ADPT: Total Utang marang Modal|Total Utang marang Modal Celldex Corp|AUPH - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi biocryst.com|VERA (Vera Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp - Utang marang Ekuitas|AbCellera - Rasio Total Utang marang Ekuitas|TRML: Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|PHAR: Rasio Total Utang marang Ekuitas|NKTR (Nektar Therapeutics Inc) - Total Utang marang Modal|Utang marang Ekuitas Zenas Biopharma, Inc. (ZBIO)|Rasio Utang marang Ekuitas Immunome Bio|Gossamer Bio, Inc. - Total Utang marang Modal|Utang marang Modal kalvista.com KALV|Rasio Total Utang marang Ekuitas SEPN (Septerna)|Pieris Pharma - Total Utang marang Modal|Utang marang Ekuitas Savara Corp|RIGL: Utang Agregat marang Ekuitas|AnaptysBio, Inc. - Utang marang Ekuitas|Koefisien Total Utang marang Modal astriatx.com|enGene (ENGN) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal RAPT|Aerovate Therapeutics Inc (JBIO) - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Aclaris Therapeutics, Inc (ACRS)|KYTX: Total Utang marang Modal|Utang marang Modal tizianalifesciences.com TLSA|Cabaletta Bio - Total Utang marang Modal|VTYX: Total Utang marang Modal|THTX (Theratechnologies Inc) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Avalo Therapeutics Inc|ELDN - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi agenusbio.com|Total Utang marang Modal Climb Bio (CLYM)|Utang marang Ekuitas Zura Bio Ltd (ZURA)|Total Utang marang Modal ATYR|Adagene Inc - Koefisien Total Utang marang Modal|IMA (Ikena Oncology, Inc.) - Utang marang Ekuitas|Shattuck Labs, Inc. (STTK) - Utang marang Modal|Rasio Total Utang marang Ekuitas equilliumbio.com EQ|Connect Biopharma Holdings Limited (CNTB) - Rasio Kabeh Utang marang Dana Pribadi|IMUX: Total Utang marang Modal|Koefisien Total Utang marang Modal ATRA|Utang marang Ekuitas InflaRx N.V. IFRX|Rasio Utang marang Ekuitas x4pharma.com (XFOR)|Adicet Bio, Inc. - Total Utang marang Modal|CELU - Rasio Total Utang marang Ekuitas|INmune Bio Corp - Rasio Total Utang marang Ekuitas|BRNS: Total Utang marang Modal|Utang marang Ekuitas Kezar Life Sciences (KZR)|sabbiotherapeutics.com (SABS) - Utang Agregat marang Ekuitas|Total Utang marang Modal Akari Therapeutics Plc|Utang marang Ekuitas ENLV|QTTB - Utang marang Ekuitas|Utang Agregat marang Ekuitas GeoVax Corp (GOVX)|Total Utang marang Modal Edesa Biotech, Inc.|Rasio Kabeh Utang marang Dana Pribadi ibioinc.com IBIO|Carisma Tx - Total Utang marang Modal|XTLB: Total Utang marang Modal|Utang marang Ekuitas boltbio.com BOLT|HCWB (HCW Biologics) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas APVO|Rasio Total Utang marang Ekuitas AIM ImmunoTech, Inc.|Total Utang marang Modal ADTX|Total Utang marang Modal GRI Bio Inc GRI|Rasio Total Utang marang Ekuitas XORTX|Rasio Kabeh Utang marang Dana Pribadi Vyome Therapeutics HIND|Total Utang marang Modal REVB (Revelation Biosciences)|INDP: Koefisien Total Utang marang Modal|SCNI (Scinai Immunotherapeutics Ltd.) - Utang marang Ekuitas|CALI (CalciMedica) - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas AFMD|Rasio Total Utang marang Ekuitas Allakos Therapeutics (ALLK)|Rasio Total Utang marang Ekuitas HOOK|Total Utang marang Modal IGMS (igmbio.com)|ITOS - Utang marang Ekuitas|Rasio Utang marang Ekuitas Ocean Biomedical Inc OCEA|TCBP (TC BioPharm (Holdings) PLC) - Total Utang marang Modal|Third Harmonic Bio Inc (THRD) - Utang marang Modal